Elevated plasma YKL-40 levels and ischemic stroke in the general population

Annals of Neurology

Volumn 68, Issue 5, 2010, Pages 672-680

  Kjaergaard, Alisa D ^a   Bojesen, Stig E ^a,b   Johansen, Julia S ^a   Nordestgaard, Brge G ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; YKL 40 PROTEIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL WALL; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOKINES; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DENMARK; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; INCIDENCE; LECTINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RISK; RISK FACTORS; STROKE;

EID: 78249263495     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22220     Document Type: Article

References (21)

1. Ross R., Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115 - 126.
2. Johansen JS, Jensen BV, Roslind A, et al. Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev 2006; 15: 194 - 202.
3. Boot RG, van Achterberg TAE, van Aken BE, et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 1999; 19: 687 - 694.
4. Agerholm-Larsen B, Tybjaerg-Hansen A, Frikke-Schmidt R, et al. ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease. Ann Intern Med 1997; 127: 346 - 355.
5. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BGI., Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 2008; 300: 2142 - 2152.
6. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A., Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298: 299 - 308.
7. Ellervik C, Tybjaerg-Hansen A, Appleyard M, et al. Hereditary hemochromatosis genotypes and risk of ischemic stroke. Neurology 2007; 68: 1025 - 1031.
8. Truelsen T, Gronbaek M, Schnohr P, Boysen G., Stroke case fatality in Denmark from 1977 to 1992: the Copenhagen City Heart Study. Neuroepidemiology 2002; 21: 22 - 27.
9. Lindgren A, Norrving B, Rudling O, Johansson BB., Comparison of clinical and neuroradiological findings in first-ever stroke. A population-based study. Stroke 1994; 25: 1371 - 1377.
10. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG., Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009; 301: 2331 - 2339.
11. Harvey S, Weisman M, O'Dell J, et al. Chondrex: new marker of joint disease. Clin Chem 1998; 44: 509 - 516.
12. Johansen JS, Bojesen SE, Mylin AK, et al. Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. J Clin Oncol 2009; 27: 572 - 578.
13. Kamstrup PR, Benn M, Tybjaerg-Hansen A, Nordestgaard BG., Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 2008; 117: 176 - 184.
14. Johansen JS., Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006; 53: 172 - 209.
15. Amarenco P, Bogousslavsky J, Caplan LR, et al. Classification of stroke subtypes. Cerebrovasc Dis 2009; 27: 493 - 501.
16. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897 - 902.
17. Bonneh-Barkay D, Wang G, Starkey A, et al. In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation 2010; 7: 34.
18. Wang Y, Ripa RS, Johansen JS, et al. YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand Cardiovasc J 2008; 42: 295 - 302.
19. Njgaard C, Host NB, Christensen IJ, et al. Serum levels of YKL-40 increase in patients with acute myocardial infarction. Coron Artery Dis 2008; 19: 257 - 263.
20. Kastrup J, Johansen JS, Winkel P, et al. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. Eur Heart J 2009; 30: 1066 - 1072.
21. Kucur M, Isman FK, Karadag B, et al. Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis 2007; 18: 391 - 396.